Nanjing Well Pharmaceutical Group Co. Ltd. Class ASSE: 603351

Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)

· Issued by Nanjing Well Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Public Issuance of Convertible Corporate Bonds (Revised Edition)

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis